Anup Kumar Trikannad Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

UAMS
Last publication 2026 Last refreshed 2026-05-16

faculty

3 h-index 22 pubs 41 cited

Metrics

  • h-index: 3
  • Publications: 22
  • Citations: 41

Selected Publications

  • 26-A-9693-ACC PREDICTION OF 1-YEAR MAJOR ADVERSE CARDIAC EVENTS IN CAR-T RECIPIENTS USING RISK SCORE MODELING: EXPANDED WHOLE-COHORT ANALYSIS (2026)
    DOI OpenAlex
  • 26-CCC-15772-ACC A CASE OF ACUTE PROTRACTED NON-ISCHEMIC CARDIOMYOPATHY PRECEDING DEVELOPMENT OF BUNDLE BRANCH RE-ENTRANT TACHYCARDIA PRECIPITATED BY CYTOKINE RELEASE SYNDROME FOLLOWING CHIMERIC ANTIGEN T-CELL THERAPY (2026)
    DOI OpenAlex
  • Critical platelet shortages and a single Institution's experience with split platelet transfusions: Can you get by with just half a unit? (2025)
    DOI OpenAlex
  • Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer. (2025)
    DOI OpenAlex
  • Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)
    DOI OpenAlex
  • Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma (2025)
    23 citations DOI OpenAlex
  • PREDICTORS OF ADVERSE CARDIOVASCULAR EVENTS AFTER CHIMERIC ANTIGEN T-CELL (CAR-T) THERAPY (2025)
    DOI OpenAlex
  • Demographic analysis of survival trends in squamous cell carcinoma of the upper 1/3 of the esophagus: a population-based study (2024)
    DOI OpenAlex
  • Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis (2024)
    DOI OpenAlex
  • Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)
    DOI OpenAlex
  • Effects of Intravenous Immunoglobulin Supplementation (IVIG) on Infections in Recipients of Teclistamab Therapy for Multiple Myeloma (MM): A Multi-Institutional Study (2024)
    7 citations DOI OpenAlex
  • Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024)
    DOI OpenAlex
  • Exploring T cell subsets as predictors of response to BCMA targeting bispecific antibody therapy in multiple myeloma. (2024)
    DOI OpenAlex
  • Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care (2024)
    2 citations DOI OpenAlex
  • A Single Center Experience of T Cell Redirecting Therapy Post Stem Cell Transplantation in Relapsed Multiple Myeloma (2024)
    1 citation DOI OpenAlex

View all publications on OpenAlex →